Heron Therapeuti

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$42,268
$36,024
$34,670
$34,233
Gross Profit
23,352
25,506
26,226
24,348
EBITDA
-4,458
-5,804
-4,109
-7,841
EBIT
-6,445
-4,798
-8,556
Net Income
-4,848
-9,235
-3,160
-10,724
Net Change In Cash
42,268
36,024
34,670
34,233
Free Cash Flow
2,940
-5,241
-9,516
2,205
Cash
25,741
18,386
20,450
28,677
Basic Shares
152,830
152,305
151,199
150,285

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$127,044
$107,672
$86,346
$88,638
Gross Profit
61,939
52,798
40,325
52,449
EBITDA
-103,792
-171,769
-214,807
-225,316
EBIT
-106,691
-174,658
-217,828
-228,163
Net Income
-110,559
-134,516
-217,662
-224,431
Net Change In Cash
127,044
107,672
86,346
88,638
Cost of Revenue
-14,597
33,240
Free Cash Flow
-60,334
-148,737
-206,376
-191,633
Cash
28,677
15,364
90,541
105,138
Basic Shares
138,135
108,876
98,471
90,774

Earnings Calls

Quarter EPS
2024-09-30
-$0.03
2024-06-30
-$0.06
2024-03-31
-$0.02
2023-12-31
-$0.07